BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1421 related articles for article (PubMed ID: 8776820)

  • 1. Efficacy of low-molecular-weight heparin and unfractionated heparin to prevent adhesion of human prostate and bladder carcinoma and melanoma cells to bovine endothelial monolayers. An in vitro study and review of the literature.
    Lersch C; Gericke D; Classen M
    Urol Int; 1996; 56(4):230-3. PubMed ID: 8776820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of coagulation and platelet adhesion to extracellular matrix by unfractionated heparin and a low molecular weight heparin.
    Krupinski K; Basic-Micic M; Lindhoff E; Breddin HK
    Blut; 1990 Nov; 61(5):289-94. PubMed ID: 2176900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bemiparin, dalteparin, and unfractionated heparin on platelet interaction with human subendothelium under flow conditions.
    González-Correa JA; Arrebola MM; Mérida F; Navas MD; López-Villodres JA; Samanes F; Cruz JP
    J Pharmacol Sci; 2008 May; 107(1):103-6. PubMed ID: 18490857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of vimentin in the inhibitory effects of low-molecular-weight heparin on PC-3M cell adhesion to, and migration through, endothelium.
    Pan Y; Lei T; Teng B; Liu J; Zhang J; An Y; Xiao Y; Han J; Pan X; Wang J; Yu H; Ren H; Li X
    J Pharmacol Exp Ther; 2011 Oct; 339(1):82-92. PubMed ID: 21733881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK; Berry LR; Monagle PT; Andrew M
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves.
    Maegdefessel L; Linde T; Krapiec F; Hamilton K; Steinseifer U; van Ryn J; Raaz U; Buerke M; Werdan K; Schlitt A
    Thromb Res; 2010 Sep; 126(3):e196-200. PubMed ID: 20659761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of systemic anticoagulation in a murine model of compensatory lung growth.
    Yu LJ; Ko VH; Tsikis ST; Dao DT; Secor JD; Pan A; Cho BS; Michell PD; Fligor SC; Kishikawa H; Puder M
    Pediatr Res; 2023 Jun; 93(7):1846-1855. PubMed ID: 36195630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of unfractionated heparin, low molecular weight heparin and r-hirudin on leukocyte adhesion in ischemia/reperfusion.
    Habazettl H; Lindert J; Baeter S; Neumann K; Kuppe H; Kuebler WM; Pries AR; Koster A
    Blood Coagul Fibrinolysis; 2004 Jul; 15(5):375-81. PubMed ID: 15205585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitor.
    Altman R; Scazziota A; Rouvier J
    Haemostasis; 1998; 28(5):229-35. PubMed ID: 10420071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anticoagulant capacity of plasmatic unfractionated heparin decreases at 23 degrees C.
    Stief TW
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):209-12. PubMed ID: 17287642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.
    Collen A; Smorenburg SM; Peters E; Lupu F; Koolwijk P; Van Noorden C; van Hinsbergh VW
    Cancer Res; 2000 Nov; 60(21):6196-200. PubMed ID: 11085545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest.
    Bereczky B; Gilly R; Rásó E; Vágó A; Tímár J; Tóvári J
    Clin Exp Metastasis; 2005; 22(1):69-76. PubMed ID: 16132580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
    Vignoli A; Marchetti M; Balducci D; Barbui T; Falanga A
    Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of unfractionated heparin and low-molecular-weight heparin on colonic anastomoses in the presence of experimental peritonitis.
    Gunerhan Y; Koksal N; Gul O; Uzun MA; Guneş P; Adaleti R
    Eur Surg Res; 2006; 38(3):353-7. PubMed ID: 16804312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfractionated heparin promotes LPS-induced endothelial barrier dysfunction: a preliminary study on the roles of angiopoietin/Tie2 axis.
    Li X; Zheng Z; Mao Y; Ma X
    Thromb Res; 2012 May; 129(5):e223-8. PubMed ID: 22455983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs].
    Nimmerfall K; Mischke R
    Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):439-44. PubMed ID: 10589154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin enhances thrombin-stimulated prostaglandin I2 production by cultured endothelial cells.
    Itoh F; Kaji T; Hayakawa Y; Oguma Y; Sakuragawa N
    Thromb Res; 1990 Feb; 57(4):481-8. PubMed ID: 2158150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.